Skip to main content
SpringerLink
Log in

Pharmacotherapy for Hypertension in Older Adults: A Systematic Review

  • Systematic Review
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Hypertension increases with increasing age. Optimal treatment of hypertension is important to reduce cardiovascular disease. Recent guidelines for hypertension have made recommendations for older adults but are supported by evidence that includes younger individuals. This systematic review evaluates the benefits and harms of antihypertensive agents in adults aged ≥65 years.

Methods

We searched MEDLINE and ClinicalTrials.gov for studies from 1996 to 2014. Eligible studies included participants aged ≥65 years with hypertension. Eligible studies had clearly defined treatment assignments, blood pressure (BP) targets, and evaluated endpoints of cardiovascular morbidity, mortality, and/or harms of antihypertensive medications. We abstracted study characteristics, cardiovascular benefits, and harms.

Results

Thirty-one articles met the inclusion criteria. Most studies compared different antihypertensive agents and/or placebo groups. These studies consistently demonstrated reduced cardiovascular morbidity and mortality compared with no treatment. Seven studies examined optimal BP targets. Strict control [systolic BP (SBP) <140 mmHg] was not consistently better than mild control (SBP <150 mmHg) for adults aged ≥65 years. Mild SBP control benefitted subjects in all age ranges over 65 years. Few studies assessed and explicitly reported harms.

Conclusions

In this review, older adults with hypertension had decreased cardiovascular morbidity and mortality with antihypertensives compared with no treatment. Strict control was not consistently better than mild control in older adults. There was enormous heterogeneity in these studies, and reporting of harms stratified by age is lacking. The current evidence is insufficient to determine the safest, most beneficial hypertension regimen in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. British Columbia Ministry of Health Services. Hypertension incidence and prevalence, age-specific rates, by gender 2001/2002. British Columbia: Ministry of Health Services; 2003.

  2. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) data, 1988–1994. http://www.cdc.gov/nchs/surveys.htm. Accessed

  3. PRIMIS+. Hypertension statistics. 2008.

  4. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. doi:10.1001/jama.2013.284427.

    Article  CAS  PubMed  Google Scholar 

  5. Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med. 2012;28:273–86.

    Article  PubMed  Google Scholar 

  6. Belmin J, Abderrhamane M, Medjahed S, et al. Variability of blood pressure response to orthostatism and reproducibility of the diagnosis of orthostatic hypotension in elderly subjects. J Gerontol A Biol Sci Med Sci. 2000;55:M667–71.

    Article  CAS  PubMed  Google Scholar 

  7. Kawaguchi T, Uyama O, Konishi M, Nishiyama T, Iida T. Orthostatic hypotension in elderly persons during passive standing: a comparison with young persons. J Gerontol A Biol Sci Med Sci. 2001;56(5):M273–80.

  8. Lewis A, Lipsitz LA. Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol A Biol Sci Med Sci. 2002;57:B115–25.

    Article  Google Scholar 

  9. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5:263–303.

    Article  CAS  PubMed  Google Scholar 

  10. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124:1046–58.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke. 2002;33:2781–8.

    Article  PubMed  Google Scholar 

  12. Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869–74.

    Article  CAS  PubMed  Google Scholar 

  13. Herrera AP, Snipes SA, King DW, Torres-Vigil I, Goldberg DS, Weinberg AD. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100:S105–12.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Uijen AA, Bakx JC, Mokkink HGA, van Weel C. Hypertension patients participating in trials differ in many aspects from patients treated in general practices. J Clin Epidemiol. 2007;60:330–5.

    Article  PubMed  Google Scholar 

  15. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    Article  CAS  PubMed  Google Scholar 

  16. Ogihara T, Matsuzaki M, Umemoto S, et al. Combination therapy for hypertension in the elderly: a sub-analysis of the combination therapy of hypertension to prevent cardiovascular events (COPE) trial. Hypertens Res. 2012;35:441–8.

    Article  CAS  PubMed  Google Scholar 

  17. Saito I, Suzuki H, Kageyama S, Saruta T. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan’s Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE). Clin Exp Hypertens. 2011;33:133–40.

    Article  CAS  PubMed  Google Scholar 

  18. Tinetti ME, Basu J. Research on multiple chronic conditions: where we are and where we need to go. Med Care. 2014;52:S3–6. doi:10.1097/MLR.0000000000000093.

    Article  PubMed  Google Scholar 

  19. National Clinical Guideline Centre (UK). Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34. London: Royal College of Physicians (UK); 2011. (NICE Clinical Guidelines, no. 127.). http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0047679/. Accessed 26 Sep 2014.

  20. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123:2434–506.

    Article  PubMed  Google Scholar 

  21. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;31(7):1281–357.

    CAS  Google Scholar 

  22. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9, W64.

  23. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;(4):CD000028.

  24. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121–3.

  25. Ogihara T, Nakao K, Fukui T, et al. The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res. 2008;31:1595–601.

    Article  PubMed  Google Scholar 

  26. Peart S, Brennan PJ, Broughton P, et al. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J. 1992;304:405–12.

    Article  Google Scholar 

  27. Lithell H, Hansson L, Skoog I, et al. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–86.

    Article  CAS  PubMed  Google Scholar 

  28. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115–27.

  29. Ogihara T, Saruta T, Rakugi H, et al.; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56:196–202.

  30. Mori Y, Nishikawa Y, Iizuka T, et al. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey. Drugs R D. 2011;11:171–90.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Saito I, Suzuki H, Kageyama S, Saruta T. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy. Clin Exp Hypertens. 2011;33:275–80.

    Article  CAS  PubMed  Google Scholar 

  32. Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med. 2012;125:981–90.

    Article  CAS  PubMed  Google Scholar 

  33. Yamazaki T, Kohro T, Chujo M, Ishigaki M, Hashimoto T. The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID). Hypertens Res. 2013;36:140–50.

    Article  CAS  PubMed  Google Scholar 

  34. Lindholm LH, Anderson H, Ekbom T, et al. Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet. 2001;358:539–44.

    Article  CAS  PubMed  Google Scholar 

  35. Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension-2 study. Lancet. 1999;354:1751–6.

    Article  CAS  PubMed  Google Scholar 

  36. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–5.

    Article  CAS  PubMed  Google Scholar 

  37. Papademetriou V, Farsang C, Elmfeldt D, et al. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the study on cognition and prognosis in the elderly (SCOPE). J Am Coll Cardiol. 2004;44:1175–80.

    CAS  PubMed  Google Scholar 

  38. Lindholm LH, Hansson L, Ekbom T, et al. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish trial in old patients with hypertension-2. J Hypertens. 2000;18:1671–5.

    Article  CAS  PubMed  Google Scholar 

  39. Ekbom T, Dahlof B, Hansson L, Lindholm LH, Schersten B, Wester PO. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-hypertension study. J Hypertens. 1992;10:1525–30.

    Article  CAS  PubMed  Google Scholar 

  40. Ekbom T, Linjer E, Hedner T, et al. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-hypertension-2. Blood Press. 2004;13:137–43.

    Article  PubMed  Google Scholar 

  41. Gueyffier F, Bulpitt C, Boissel JP. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999;353:793–6.

    Article  CAS  PubMed  Google Scholar 

  42. Furberg CD, Wright JT Jr, Davis BR, et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Am Med Assoc. 2002;288:2981–97.

    Article  CAS  Google Scholar 

  43. Cushman WC, Davis BR, Pressel SL, et al. Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial. J Clin Hypertens. 2012;14:20–31.

    Article  Google Scholar 

  44. Wing LMH, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583–92.

    Article  CAS  PubMed  Google Scholar 

  45. Solfrizzi V, Scafato E, Frisardi V, et al. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Age. 2013;35:441–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Hansson L, Zanchetti A. The hypertension optimal treatment (HOT) study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Press. 1995;4:313–9.

    Article  CAS  PubMed  Google Scholar 

  47. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–9.

    Article  CAS  PubMed  Google Scholar 

  48. Peters R, Beckett N, Burch L, et al. The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET). Age Ageing. 2010;39:609–16.

    Article  PubMed  Google Scholar 

  49. Beckett N, Peters R, Tuomilehto J, et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to hypertension in the very elderly randomised controlled trial. BMJ. 2011;344:d7541.

    Article  PubMed  Google Scholar 

  50. Bulpitt CJ, Beckett NS, Cooke J, et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003;21:2409–17.

    Article  CAS  PubMed  Google Scholar 

  51. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003;290:2805–16.

    Article  CAS  PubMed  Google Scholar 

  52. Wake Forest University Baptist Medical Center. Systolic blood pressure intervention trial: memory and cognition in decreased hypertension [ClinicalTrials.gov identifier NCT01206062]. US National Institutes of Health, ClinicalTrials.gov. http://clinicaltrials.gov/show/NCT01206062. Accessed 20 Sep 2013.

Download references

Funding

The research of this paper was not supported by grants or organizations. The investigators retained full independence in the conduct of this research.

Acknowledgments

The authors would like to thank Dr. Elena Andresen for the mentorship she has provided our research group. None of the authors have any potential conflict of interest that might be relevant to the contents of this manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, College of Pharmacy, Oregon State University, Corvallis, USA

    Leah M. Goeres, Craig D. Williams & David S. H. Lee

  2. Department of Pharmacy Practice, College of Pharmacy, Oregon Health and Science University, Portland, OR, USA

    Leah M. Goeres, Craig D. Williams & David S. H. Lee

  3. Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, USA

    Elizabeth Eckstrom

  4. 2730 SW Moody St., Mail code: CL5CP, Portland, OR, 97201, USA

    Leah M. Goeres

Authors
  1. Leah M. Goeres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Craig D. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Eckstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David S. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leah M. Goeres.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goeres, L.M., Williams, C.D., Eckstrom, E. et al. Pharmacotherapy for Hypertension in Older Adults: A Systematic Review. Drugs Aging 31, 897–910 (2014). https://doi.org/10.1007/s40266-014-0219-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-014-0219-8

Keywords

Search

Navigation